SEC Form 4 · accession 0001681871-16-000004
Bausch Health Companies Inc. · BHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Herendeen
Officer — EVP, Chief Financial Officer
Period of report
Aug 22, 2016
Accepted (ET)
Aug 24, 2016 · 4:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885590
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, no par valueF1 | Aug 22, 2016 | A | 150,000 | $0.00 | A | 150,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Options (right to purchase)F2 | $28.74 | Aug 22, 2016 | A | 1,000,000 | A | — | Aug 22, 2026 | Common Shares, no par value | 1,000,000 | 1,000,000 | D |
Explanation of responses
- F1Represents Restricted Share Units ("RSUs") representing a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc. The RSUs vest one-third on each of the three anniversaries following the date of grant, subject to the reporting person's continued service.
- F2The options vest in equal installments on each of the first three anniversaries of the date of grant.